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Abstract 
Background: Arterial hypertension (AH) is the most common disease of the cardiovas-
cular system. Intracellular chemical and oxidative stress, which can be associated both 
with direct exposure to toxic xenobiotics and with their excessive activation during bio-
transformation, may lead to endothelial dysfunction and increased risk of AH develop-
ment. The aim of the study: To investigate the association of single nucleotide poly-
morphisms of genes involved in the biotransformation of xenobiotics (rs1048943 
CYP1A1, rs762551 CYP1A2, rs1056836 CYP1B1, rs1799930 NAT2, rs1800566 NQO1, 
rs11045642 MDR1) with predisposition to arterial hypertension. Materials and meth-
ods: A total of 702 patients with AH (307 men, 395 women; mean age 55 years) and 
857 gender- and age- matched relatively healthy volunteers (406 men, 451 women; 
mean age 53 years) were recruited for the study. Genotyping of SNPs were done using 
TaqMan-based PCR. Results: Comparative analysis of genotype frequencies (log-
additive regression model was used, all calculations were performed with adjustment for 
gender, age) showed that SNP rs762551 CYP1A2 was associated with a decreased risk 
of AH (ORadj=0.85, 95%CIadj=0.73-0.99; Padj=0.038); SNP rs1045642 MDR1 (ABCB1) 
was associated with an increased risk of AH (ORadj=1.20, 95% CIadj=1.04-1.39; 
Padj=0.013). Moreover, SNP rs762551 CYP1A2 was associated with the age of manifes-
tation of arterial hypertension (Differenceadj=1.51; 95%CIadj=0.22-2.80) and cholesterol 
level (Differenceadj= -0.15; 95% Cladj = -0.29 - -0.01). Conclusion: Thus, in this study, 
for the first time, there was found the association of rs762551 CYP1A2 and rs1045642 
ABCB1 (MDR1) with arterial hypertension in Russians. 
Keywords: arterial hypertension; cytochrome P450; biotransformation of xenobiotics; 
rs762551; CYP1A2; rs1045642; MDR1; ABCB1 
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Introduction. Arterial hypertension 
(AH) is the most common disease of the car-
diovascular system.  More than 30% of the 
world's adult population suffer from AH [1]. 
From a genetic point of view, AH is a multi-
factorial polygenic hereditary disease. 
Numerous studies prove that various 
aerosol polycyclic aromatic hydrocarbons 
(PAHs) are the main source of organic toxic 
chemicals with potential effects on the cardi-
ovascular system [2]. PAHs are widely spread 
in the environment: they are found in cigarette 
smoke, they are formed during cooking with 
incomplete combustion of organic materials 
such as coal and oil products, they are by-
products of various industrial enterprises [3]. 
Intracellular chemical and oxidative stress, 
which can be associated both with direct ex-
posure to toxic xenobiotics and with their ex-
cessive activation during biotransformation, 
are the cause of endothelial dysfunction. In 
particular, it was shown that nitrated and oxi-
dized polyaromatic hydrocarbons can reduce 
both the activity of endothelial NO synthase 
(eNOS) and NO production through mecha-
nisms associated with the effect of phos-
phorylated eNOS on eNOS mRNA expression 
and eNOS protein expression [4]. Considering 
the crucial role of NO in the regulation of 
vascular tone and endothelial dysfunction [5], 
it is obvious that variations in genes involved 
in different stages of biotransformation of xe-
nobiotics can be a risk factor for the devel-
opment of arterial hypertension through par-
ticipation in key pathogenetic mechanisms of 
AH development. 
Cytochrome P4501A1 (CYP1A1) is an 
important member of the CYP family and is 
responsible for the metabolism of a large 
number of xenobiotics, as well as some en-
dogenous substrates. In particular, CYP1A1 
acts as a major enzyme in the metabolism of 
PAHs [6]. CYP1A1 is also involved in the 
production of vasoactive substances based on 
arachidonic acid – epoxyeicosatrienoic acids 
(EETs) and hydroxyeicosatetraenoic acid 
(HETE), which are endogenous defense 
mechanisms against cardiovascular disease 
[7]. Moreover, CYP1A1 is also involved in 
the oxidative metabolism of estradiol and es-
trone [8]. The rs1048943 CYP1A1 genetic 
variant is one of the most functionally signifi-
cant. Substitution of A for G in the 7th exon 
of the gene leads to the replacement of Isoleu-
cine with Valine in the structure of the en-
zyme (Ile462Val). This SNP is located in the 
heme-binding region of the protein CYP1A1 
and can lead to a twofold increase in enzyme 
activity [9]. 
CYP1A2 encoded by the CYP1A2 gene, 
participates in the metabolism of a wide range 
of xenobiotics, such as heterocyclic aromatic 
amines and PAHs [10]. CYP1A2 is also an 
important enzyme, which is responsible for the 
metabolism of caffeine. CYP1A2 expression is 
induced by environmental chemicals and is 
highly variable between individuals [11]. 
CYP1A2 gene is highly polymorphic. The 
rs762551 CYP1A2 genetic variant can lead to a 
2-3-fold increase in protein activity [12]. 
CYP1B1 – cytochrome P450 product – 
oxidizes various compounds such as steroids 
(17-beta-estradiol), fatty acids, retinoids and 
xenobiotics including PAHs. In blood vessels, 
CYP1B1 is expressed predominantly in vascu-
lar smooth muscle cells, to a lesser extent – in 
endothelial cells [13]. In animal experiments, 
it was shown that the endothelial dysfunction 
observed in angiotensin II-induced hyperten-
sion in mice was prevented by silencing the 
CYP1B1 gene [14]. The most studied 
rs1056836 genetic variant in the CYP1B1 
gene leads to the replacement of Leucine with 
Valine at the 432 position of the encoded pro-
tein [15].   
NAT2 is a phase II xenobiotic biotrans-
formation enzyme which carries out conjuga-
tion of exogenous arylamine-containing sub-
stances, components of some drugs, caffeine 
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N-acetyltransferase is located on chromosome 
8p22. Variations in the NАТ2 gene lead to a 
change in the level of functional activity of 
isoniazid acetylation, which has been classi-
fied as fast, intermediate, and slow [17]. 
Amino acid replacement 590G>А (Arg>Gln; 
rs1799930) leads to a change in the functional 
activity of the enzyme. Slow acetylation phe-
notype associated with the АА NAT2 geno-
type is unable to conjugate to metabolites or 
toxins; GA heterozygotes have intermediate 
enzyme activity. 
NAD(P)H quinone oxidoreductase 1 
(NQO1) – an enzyme of phase II of biotrans-
formation of xenobiotics – catalyses the re-
duction of various quinones using NAD (P) H 
as an electron donor. The transformation of 
quinones to hydroquinones using NQO1 rep-
resents an important mechanism of cell de-
fence against oxidative and chemical stress 
[18]. Single-nucleotide polymorphism 
rs1800566 NQO1 in the 6th exon of the gene 
leads to the substitution of Proline for Serine 
in the 187
th
 amino acid. It was shown that the 
187SS variant genotype causes a complete 
loss of the enzymatic activity of NQO1, while 
in heterozygotes 187PS there is an almost 
threefold decrease in the enzyme activity.  
The multidrug resistance gene (MDR1) 
encodes an integrated transmembrane protein, 
P-glycoprotein, which plays an important role 
in the bioavailability of certain drugs, as well 
as in the protection of cells from toxic sub-
stances and metabolites through the action of 
an ATP-dependent mechanism of "cell out-
flow" [19]. MDR1 has broad substrate speci-
ficity. Of more than 50 single nucleotide pol-
ymorphisms of MDR1, the functionally sig-
nificant C3435T (rs1045642) is the most 
widely studied [20].  
The aim of the study was to investigate 
the association between common SNP in 
genes encoding xenobiotics biotransformation 
enzymes (rs1048943 CYP1A1, rs762551 
CYP1A2, rs1056836 CYP1B1, rs1799930 
NAT2, rs1800566 NQO1, rs1045642 MDR1) 
and the risk of AH. 
Materials and methods. A total of 
1559 unrelated Russian individuals from the 
Kursk region were examined; written in-
formed consent was obtained from all partici-
pants prior to entering the study. This study 
included 702 patients with diagnosis of arteri-
al hypertension. AH patients were hospital-
ized in the cardiac units of the Kursk Region-
al Clinical Hospital and the Kursk City Clini-
cal Emergency Hospital in the period 2011-
2017 [21, 22, 23]. The AH group included 
patients with systolic blood pressure (SBP) 
≥140 mm Hg. and/or diastolic blood pressure 
(DBP)≥90 mm Hg, as well as patients who 
received antihypertensive therapy. Exclusion 
criteria: symptomatic arterial hypertension, 
acute inflammatory diseases, autoimmune 
diseases, severe kidney or liver disease, onco-
logical pathology, pregnancy. Patients with 
ischemic heart disease, cerebral stroke, diabe-
tes mellitus were also excluded from the 
study. The control group consisted of 857 
gender- and age-matched healthy individuals, 
without a history of cardiovascular and cere-
brovascular diseases and with normal level of 
blood pressure (Table 1). The control group 
was formed from relatively healthy volun-
teers, as well as during professional examina-
tions at industrial enterprises, in medical insti-
tutions of Kursk and the Kursk region. The 
formation of AH group and control group was 
carried out using a continuous method. 
The study was approved by the Region-
al Ethics Committee of Kursk State Medical 
University. All patients signed a voluntary 
informed consent to participate in the study. 
Venous blood samples were obtained from all 
individuals. Genomic DNA was isolated from 
peripheral blood using the standard phenol-
chloroform extraction procedure. The main 
criteria for SNP selection were the functional 
significance of polymorphism and the fre-
quency of the minor allele over 5%. Genotyp-
ing of rs1048943 CYP1A1, rs762551 
CYP1A2, rs1056836 CYP1B1, rs1799930 
NAT2, rs1800566 NQO1, rs1045642 MDR1 
was performed by TaqMan-based PCR using 
CFX96 detection system (Bio-Rad, USA). 
Regenotyping of 10% of the studied samples, 
selected on a random basis and in the absence 
of information about the status of the disease, 
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Age. Ме [Q1; Q3] 55 [48; 62] 53 [49; 59] 0.84 
Gender 
Male. N(%) 307(43.7) 406(47.4) 
1.92 (0.17) 
Female. N(%) 27(45.8) 451(52.6) 
Smoking 
Yes. N(%) 182 (29.8%) 295 (37.8%) 
0.0036* 
No. N(%) 429 (70.2%) 486 (62.2%) 
Maximumsystolicbloodpressure 230[200; 250] - - 
Maximumdiastolicbloodpressure 120 (115; 140) - - 
Total cholesterol. Ме [Q1; Q3] 4.80 [4.20; 5.43] - - 
Triglycerides. Ме [Q1; Q3] 1.985 [1.44; 2.46] - - 
Glucose level. Ме [Q1; Q3] 4.58 [4.10; 5.41] - - 
Age of AH manifestation.  
Ме [Q1; Q3] 
33.5 [25.0; 44.0] 
- - 
Note: * –shows statistically significant differences between groups. 
 
 
To assess the associations of genotypes 
with predisposition to AH, the odds ratio 
(OR) and 95% confidence interval (CI), cal-
culated for the log-additive regression model, 
were used. All calculations were performed 
with corrections for gender and age in the 
SNPStats program available online 
(https://www.snpstats.net/start.htm). To as-
sess the regulatory potential of SNPs, bioin-
formatic resources available online were used: 




Results and discussion. The analysis of 
Hardy-Weinberg equilibrium was carried out 
in the control group. The distribution of geno-
type frequencies for all studied SNPs, except 
for rs762551 CYP1A2, corresponded to the 
Hardy-Weinberg equilibrium (P> 0.05). For 
rs762551 CYP1A2, we revealed a decrease in 
observed heterozygosity (0.40) versus ex-
pected (0.45); P <0.01.  
SNP rs762551 CYP1A2 was associated 
with a decreased risk of AH (OR=0.85, 95% 
CI=0.73-0.99, P=0.038). SNP rs1045642 
ABCB1 was associated with an increased risk 
of AH (OR=1.20, 95% CI=1.04-1.39, 
P=0.013) (Table 2). 
Subsequent analysis of the relationship 
of the studied genetic variants with clinical and 
laboratory parameters in patients with AH re-
vealed an association of rs762551 CYP1A2 with 
the age of manifestation of AH and cholesterol 
level: carriers of the C/C genotype had the low-
est cholesterol levels and the latest manifesta-
tion of hypertension (Table 3). It should also be 
noted that SNP rs1799930 NAT2 was associated 
with blood glucose levels. 
Our study revealed an association of 
rs762551 CYP1A2 with the decreased risk of 
AH. This association was discovered for the 
first time in the population of Central Russia. 
It is important that rs762551 CYP1A2 was 
associated with age at onset of AH and cho-
lesterol levels. The CYP1A2 gene encodes a 
member of the cytochrome P450 superfamily 
of enzymes. Cytochrome P450 proteins are 
monooxygenases that catalyse reactions in-
volved in the metabolism of xenobiotics and 
the synthesis of sex steroids, cholesterol, and 
other lipids. The protein encoded by this gene 
is localized in the endoplasmic reticulum, and 
its expression is induced by polycyclic aro-
matic hydrocarbons (PAHs), some of which 
are found in components of cigarette smoke. 
The endogenous substrate of the enzyme is 
unknown; however, it is able to metabolize 
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Table 2  
Analysis of associations of SNP in genes encoding xenobiotic biotransformation enzymes  
with the development of arterial hypertension 


















I/I 643 (85.2%) 548 (86.2%) 
0.91 
(0.69-1.22) 
0.54 I/V 108 (14.3%) 84 (13.2%) 





A/A 372 (46.6%) 311 (51%) 
0.85  
(0.73-0.99) 
0.038 A/C 318 (39.9%) 238 (39%) 





L/L 270 (32.9%) 199 (31.4%) 
1.05  
(0.91-1.22) 
0.5 L/V 397 (48.4%) 313 (49.4%) 





G/G 386 (49%) 309 (48.4%) 
0.98  
(0.83-1.15) 
0.79 G/A 329 (41.8%) 278 (43.6%) 





P/P 485 (63.1%) 392 (62.5%) 
0.98 
(0.82-1.17) 
0.82 P/S 239 (31.1%) 206 (32.9%) 





C/C 273 (33.4%) 180 (28.4%) 
1.20  
(1.04-1.39) 
0.013 C/T 384 (47%) 306 (48.3%) 
T/T 160 (19.6%) 147 (23.2%) 
 
Note: all calculations are performed with respect to the minor allele; statistically significant associations are marked in 
bold; 1 – the absolute number and % of individuals with the analyzed genotype; 2 – odds ratio and 95% confidence in-
terval (calculated for the log-additive regression model) corrected for gender and age; 3 – P-value for log-additive re-
gression model with correction for sex and age. 
Table 3 
Statistically significant associations of studied genetic variants with clinical 
 and laboratory parameters of hypertensive patients 
 










Age of manifestation of 
AH CYP1A2 
(rs762551) 
A/A 41.96 (1.95)  
1.51 
(0.22 - 2.80) 
0.023 A/C 44.12 (1)  






A/A 5.31 (0.07) 
-0.15  
(-0.29 - -0.01) 
0.032 A/C 5.14 (0.08) 
C/C 4.99 (0.15) 
Blood glucose levels 
NAT2 
(rs1799930) 
G/G 5.43 (0.12) 
-0.24  
(-0.47 - -0.01) 
0.046 G/A 5.26 (0.11) 
A/A 4.94 (0.13) 
Note: the results of the log-additive model are presented. All calculations were performed with a correction for the sex 
and age (adj); 1 – Mean ± StD - an indicator of the mean and standard deviation; 2 – the difference in mean values 
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Previous studies have already shown an 
association of rs762551 polymorphism with 
blood pressure variability and hypertension 
[24].It is known that the studied rs762551 
CYP1A2 is in linkage disequilibrium with the 
SNP rs1378942 (HapMap CEU), which is lo-
cated in the CYP1A2 gene cluster and showed 
the strongest association with diastolic blood 
pressure in Europeans [25]. Moreover, an as-
sociation between rs762551 and the risk of 
AH was shown in the study by GuessousI, et 
al [26], who noted a negative association of 
rs762551 with hypertension in non-smokers, 
modified by caffeine intake. The previous 
studies of CYP1A2 in mice have demonstrated 
an important role for this enzyme in oxidative 
stress [27] and in lipid metabolism [28], 
which could explain the effect of the 
rs762551 CYP1A2 on cholesterol levels found 
in our study. It was shown that CYP1A2 -/- 
mice were characterized by a change in the 
expression of genes involved in the pathways 
of cholesterol biosynthesis and fatty acid me-
tabolism. Moreover, in patients with cardio-
vascular diseases, which were characterized 
by low CYP1A2 activity, there was an in-
creased level of inflammatory cytokines that 
may be involved in the pathogenesis of cardi-
ovascular diseases [29]. These observations 
indicate that low CYP1A2 levels have ad-
verse biological effects that may explain not 
only the increased risk of AH, but also im-
paired cholesterol metabolism. 
Bioinformatics analysis was performed 
to explain the functional effects of rs762551 
CYP1A2. According to the QTLbase, the car-
riage of the protective C allele is associated 
with 17 cis-mQTLs associated with a decrease 
in methylation of CpG sites in CYP1A2 (Table 
4). Because a decrease in methylation can lead 
to an increase in gene expression, the protec-
tive effects of the C allele can also be mediated 
by cis-mQTL. At the same time, for the risk 
allele A, 2 cis-hQTLs were found associated 
with a decrease in acetylation at the 27th lysine 
residue on the histone H3 protein in CD14+ 
monocytes and CD16+ neutrophils in periph-
eral blood and, therefore, with a potential de-
crease in CYP1A2 expression (Table 4). 
Table 4 
Сis-mQTL/cis-hQTL, associated withrs762551 CYP1A2  
 
№ CpGsite (genomicregion) Effect size (beta) P-level Tissue 
Сis-mQTL associated with a decrease in methylation of CpG-sites in carriers of the protective allele C rs762551 CYP1A2 
1.  cg20927731 (chr15:74726561) -0.029 0.0194 blood 
2.  cg18176723 (chr15:75336436) -0.069 6.25×10-6 blood 
3.  cg13055199 (chr15:75136278) -0.119 3.07×10-11 blood 
4.  cg20801110 (chr15:75136007) -0.029 0.0146 blood 
5.  cg06285340 (chr15:74659901) -0.018 0.0157 blood 
6.  cg03289416 (chr15:75166202) -0.053 0.00013 blood 
7.  cg02696790 (chr15:75250997) -0.038 0.000154 blood 
8.  cg20997706 (chr15:74907203) -0.027 0.0147 blood 
9.  cg27140083 (chr15:75230280) -0.034 0.00241 blood 
10.  cg13316255 (chr15:75165642) -0.026 0.0253 blood 
11.  cg00629941 (chr15:75287862) 0.025 0.0335 blood 
12.  cg20552236 (chr15:75090958) -0.024 0.00637 blood 
13.  cg04629595 (chr15:74592566) -0.034 0.0195 blood 
14.  cg21565421 (chr15:74592665) -0.03 0.0192 blood 
15.  cg04877966 (chr15:75135169) -0.024 0.00138 blood 
16.  cg00516515 (chr15:75091516) -0.028 0.00257 blood 
17.  cg10785927 (chr15:74753902) -0.016 0.023 blood 
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According to the HaploReg database 
(v4.1), this polymorphism is associated with 
trans-eQTLs for the ULK3 gene in visceral 
and subcutaneous adipose tissue, pancreas, 
whole blood (ULK3 encodes serine/threonine 
kinase protein, which acts as a regulator of 
autophagy); for the CSK gene in whole blood 
(tyrosine protein kinase CSK; non-receptor 
tyrosine protein kinases, which play an im-
portant role in the regulation of cell growth, 
differentiation, migration, immune response) 
(https://pubs.broadinstitute.org/mammals/hapl
oreg/detail_v4.1.php ? query = & id = 
rs762551). Therefore, rs762551-trans-eQTLs 
may be associated with the development of 
AH through mechanisms involved in the 
regulation of growth, differentiation, cell mi-
gration, and autophagy processes. 
Thus, the present study provided addi-
tional evidence that CYP1A2 is an important 
gene for cardiovascular diseases susceptibility. 
Another gene involved in xenobiotics 
biotransformation and associated with AH 
was MDR1 (multidrug resistance gene). It was 
found that the genetic variant 3435C> T 
(rs1045642) ABCB1 (MDR1) was associated 
with an increased risk of AH. P-glycoprotein, 
a protein from the ABCB-transporter family, 
is involved in the active transport of xenobiot-
ics from the intracellular to the extracellular 
space [30]. This trans-membrane protein is 
expressed in numerous tissues, including the 
vascular endothelial cells.  P-glycoprotein is 
encoded by the ABCB1 gene. The ABCB1 
gene is located on the long arm of chromo-
some 7 and consists of 29 exons 
(https://www.ncbi.nlm.nih.gov/gene/5243). 
Many single nucleotide polymorphisms have 
been found in this gene; however, the most 
studied genetic variant is rs1045642.Variation 
of C3435T in exon 26 does not lead to an 
amino acid substitution, however, it affects 
gene expression, in particular, it reduces the 
stability of mRNA and, as a consequence, the 
activity of the transmembrane P-glycoprotein 
[31]. In a study of the Chinese Han popula-
tion, rs1045642 ABCB1 has been shown to be 
associated with blood pressure [32]. It was 
also found that this SNP is associated with an 
increased risk of AH in patients with chronic 
kidney disease [33]. 
The association of C3435T ABCB1 with 
AH can be explained by three mechanisms. 
Firstly, it is known that P-glycoprotein is in-
volved in the secretion of aldosterone in the 
adrenal glomerular zone [34]. Secondly, ani-
mal studies have shown that P-glycoprotein is 
involved in the transport of oxidized glutathi-
one and thus is associated with oxidative 
stress – one of the main triggers of AH [35]. 
Thirdly, P-glycoprotein significantly affects 
endothelium-dependent vasodilation, reducing 
NO synthesis [36].  
Protective allele C rs1045642 ABCB1 
may be associatedwith the increased gene ex-
pression in blood cells by cis-eQTL-mediated 
mechanisms (Table 5).  
According to HaploReg resource data 
(v4.1), rs1045642 ABCB1 is located in the 
region of DNA binding with modified histone 
H3K27ac marking enhancers (in peripheral 
blood cells), with modified histone H3K9ac 
marking promoters (in primary mononuclear 
cells of peripheral blood).  
N-acetyltransferase 2 (NAT2) is phase 
II xenobiotics biotransformation enzyme 
which plays an important role in both detoxi-
fication and activation of many xenobiotics 
[16]. Diabetes mellitus (DM) is one of the 
diseases whose association has been studied 
in relation to acetylation phenotypes. Previous 
studies have already shown a positive associa-
tion between air pollutants and insulin re-
sistance in subjects with the GG genotype of 
the rapid acetylator phenotype rs1799930 
NAT2 [37]. Another study also showed that 
T2DM patients with the rapid acetylator phe-
notype (carriers of the GG genotype) had sig-
nificantly higher absolute insulin levels and 
lower insulin sensitivity compared with pa-
tients characterized by a slow acetylator phe-
notype [38]. 
Thus, despite the fact that there were no 
patients with diabetes mellitus among patients 
with AH, it can be assumed that the genetical-
ly determined type of acetylator by the single 
nucleotide polymorphism rs1799930 NAT2 
can modify the complex of quantitative phe-
notypic manifestations associated with the 
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Association of cis-eQTL with level of ABCB1 expression in carriers of the protective C allele rs1045642 ABCB1 
1. ABCB1 NA 3.0×10
-7
 Peripheralblood 
2. ABCB1 1.855966 0.0635 Blood (B-cells) 
3. ABCB1 2.20673 0.0273 Blood (monocytes) 









Note: the data is provided by the QTLbase resource (http://mulinlab.org/qtlbase). 
 
Conclusion. Thus, in this study, for the 
first time, the association of rs762551 
CYP1A2 and rs1045642 ABCB1 (MDR1) with 
AH in the Russians was found, which pro-
vides additional evidence for the role of 
«chemical stress» in the pathogenesis of car-
diovascular pathology. It is also worth noting 
that bioinformatics analysis revealed a high regu-
latory potential of rs762551 and rs1045642, 
suggesting a potentially important role of epige-
netic mechanisms in the regulation of gene ex-
pression. From a practical point of view, the 
results obtained can be used to develop new 
approaches to the prevention and treatment of 
cardiovascular diseases, based on the ―fight‖ 
against toxic xenobiotics of the environment. 
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